Cargando…
Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study
INTRODUCTION: Studies evaluating BNT162b2 mRNA Covid-19 vaccine safety excluded subjects with a previous history of COVID-19 infection. The aim of our study was to focus on the tolerance of this vaccine this population. METHODS: An anonymous self-reporting survey related to safety and tolerance of v...
Autores principales: | Baldolli, Aurelie, Michon, Jocelyn, Appia, Fanny, Galimard, Caroline, Verdon, Renaud, Parienti, Jean Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220908/ https://www.ncbi.nlm.nih.gov/pubmed/34210574 http://dx.doi.org/10.1016/j.vaccine.2021.06.054 |
Ejemplares similares
-
Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project
por: Polewska, Karolina, et al.
Publicado: (2021) -
Vaccination perception and coverage among healthcare students in France in 2019
por: Baldolli, Aurélie, et al.
Publicado: (2020) -
Mycobacterium genavense Infections in Immunocompromised Patients Without HIV: Case Series of Solid Organ Transplant Patients and Literature Review
por: Baldolli, Aurélie, et al.
Publicado: (2022) -
Évaluation de l'immunogénicité après vaccination COVID-19 hétérologue ChAdOx1-nCoV19/BNT162b2 et homologue BNT162b2/BNT162b2– Cohorte ANRS0001S COV-POPART
por: Lachâtre, M., et al.
Publicado: (2022) -
Safety and BNT162b2 mRNA COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2021)